Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Rznomics
company
About
Rznomics is a biotechnology company.
- 11 - 50
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- ₩37.20B
- Industries
- Biopharma,Biotechnology
- Founded date
- Aug 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
This is a biotechnology company founded by professor Lee Sung-wook's labThey are working on the development of gene therapy products for liver cancer through the development of gene therapy products.It was selected by the TIPS program and was recognized for excellence in technology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
₩59.70B
Rznomics has raised a total of
₩59.70B
in funding over 2 rounds. Their latest funding was raised on
Jun 8, 2022 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 8, 2022 | Series C | ₩37.20B | 1 | — | — | Detail |
| Apr 16, 2021 | Series B | ₩10.50B | 1 | — | — | Detail |
| Oct 30, 2019 | Series A | ₩12B | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
4
Rznomics is funded by 4 investors.
Aon plc
and Synergy IB Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Aon plc
|
— | Series C |
Synergy IB Investment
|
— | Series B |
|
|
— | Series A |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
